Support vital childhood cancer research

Donate or Share your achievement!

Thank you so much to everyone for attending Run2Cure 2022 at The Domain!

The atmosphere, weather and fundraising was exceptional. Current fundraising is over $280,000!

Fundraising remains open till the end of the month, so there's still time to share your page and your achievement if you have not yet done so.

Alternatively, donate to Ethan's fundraising – click here.

Thank you for your support.

Click here to support Ethan's fundraising!

Run2Cure Domain

Sunday 3 April 2022

Our Run2Cure 2022 event offered a fun day out for families and individuals alike. We launched our first ever half marathon event too which was complemented by our 10k, 5k, 3k, 1k Dash and 1k Little Heroes Walk.

More info regarding Run2Cure

RACE RESULTS

CONGRATULATIONS to all participants at Run2Cure 2022 and thank you for joining us this year! Please click on the link below for race results, provided by Multi Sport Australia.

Find Race Results Here!

Event Day Photographs

Find your Run2Cure event photos here! Raceatlas is generously donating 20% of their proceeds from all race photos purchased back to Neuroblastoma Australia. So purchase your photo memories now and continue giving back to Run2Cure.

Click Here for Race Photos

Run2Cure Local

Can't join us this April in The Domain? Host your very own Run2Cure Local run/walk! Hosting your own event offers you the flexibility on date, location and how you'd like to manage your fundraiser.

Read more here

Support vital research into a cure

It’s a shock to learn that children, particularly those with rare diseases like neuroblastoma, come last in the world of cancer research. Our Run2Cure Superheroes and their families have shared their stories to help raise awareness of this devastating cancer. Get to know them and find out why research is so important through their stories on our Superheroes pages.

Support our search for a cure

2022 Fundraising Leaderboards

Congratulations to the below individuals and teams, topping our leaderboard for 2022.

Latest News

View all